Surgical Oncology Research

The surgical oncology research section is composed of three highly interactive research laboratories focused on developing novel cancer therapies with a bench to bedside translational approach. Areas of priority include:  cancer immunotherapy, tumor angiogenesis, and the development of human tumor models to predict drug efficacy. All three laboratories are highly integrated between themselves and with other research groups within the Hollings Cancer Center.

Surgical Oncology Laboratories:

Dr. DeMore studies angiogenesis as it relates to tumor progression and develops novel angiogenesis inhibitors.

Publication Search on PubMed 
Search on "Klauber-Demore"
Search on "Klauber"

Shikhar Mehrotra, Ph.D.

Dr. Mehrotra studies mechanisms for T cell immunity, T cell tolerance and how these can be modulated to control tumor and autoimmunity. \